Frankfurt/Main, 09.10.2024 – Nasdaq-listed Bruker Corporation has acquired Dynamic Biosensors GmbH, a Munich-based pioneer in single-cell interaction cytometry for drug discovery. Bruker and Dynamic Biosensors share the common goal of developing a range of instruments, workflows and consumables for the study of molecule-cell interactions in research-based drug discovery.
A team led by lead partner Dr. Hendrik Hirsch provided comprehensive legal advice to Bruker on this transaction. The parties have agreed not to disclose further details of the transaction.
Bruker is a long-standing client of CMS. The US company regularly relies on the expertise of CMS in acquisitions and divestitures. The current advice is further proof of the successful cooperation.
CMS Germany
Dr. Hendrik Hirsch, Lead Partner
Dr. Berrit Roth-Mingram, Co-Lead, Counsel
Dr. Maximilian Stark, Senior Associate
Dr. Till Alexander von Poser, Associate
Luca Eckrich, Associate, all Corporate/M&A
Dr. Roland Wiring, Partner, Regulatory & Life Sciences
Dr. Thomas Hirse, Partner
Sebastian Vautz, Senior Associate, both IP
Dr. Michael Bauer, Partner
Stefan Lehr, Partner
Moritz Pottek, Counsel
David Rappenglück, Associate, all Antitrust, Competition & Trade
Dr. Boris Alles, Partner
Dela Herr, Senior Associate
Lisa Hermann, Senior Associate, all Labor, Employment & Pensions
Dr. Christian Scherer, Partner
Dr. Jakob Steiff, Partner
Dr. Florian Kuhlmann, Senior Associate
Nicole Köppen, Senior Associate, all Public Law
Jörg Schrade, Partner, Tax
Press Contact
presse@cms-hs.com
